Bias, Biostatistics, and Prognostic Factors

Bias, Biostatistics, and Prognostic Factors

Bibliographic Details
Main Author:	Mithat Gonen
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-02-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.12

Similar Items

Analysis of prognostic factors in 352 lung cancer patients with brain metastases
by: Hao BAI, et al.
Published: (2008-02-01)

Great Potential of miRNAs as Predictive and Prognostic Markers for Cancer
by: William CS CHO
Published: (2013-01-01)

Tumor-stroma Ratio is An Independent Prognostic Factor of Non-small Cell Lung Cancer
by: Zhaofeng WANG, et al.
Published: (2013-04-01)

Prognostic Factors in 408 Elderly Lung Cancer Patients More than 70 Years Old
by: Hua ZHENG, et al.
Published: (2011-06-01)

Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery
by: Zhenyu YANG, et al.
Published: (2020-01-01)

Analysis of Prognostic Factors of 80 Advanced NSCLC Patients Treated with Gefitinib for more than 6 Months
by: Ling DAI, et al.
Published: (2010-11-01)

Prognostic predictors for non-small cell lung cancer patients with brain metastasis after radiotherapy
by: Qiuhong FAN, et al.
Published: (2008-06-01)

The Prognostic Value of Micrometastasis in Non-small Cell Lung Cancer
by: Yuanyuan LEI, et al.
Published: (2013-09-01)

Advances of Tissue Factor in Lung Cancer
by: Chengcheng XU, et al.
Published: (2010-09-01)

Combined Inhibition of Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways in Non–small Cell Lung Cancer Therapy
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

Prognostic Factors in Patients with Advanced Lung Adenocarcinoma Treated with Icotinib
by: ZHANG Hongbin, et al.
Published: (2022-11-01)

Analysis of Prognostic Factors in Patients with Stage IV Lung Adenocarcinoma after Failure of Second-line EGFR-TKIs Therapy
by: Shujun DAI, et al.
Published: (2013-01-01)

Transcription Factor Snail and Epithelial-Mesenchymal Transition of Tumor
by: Lin LI, et al.
Published: (2011-09-01)

The Roles of P120-catenin and the Ttranscriptional Factor Kaiso for the Tumor
by: Cheng SUN, et al.
Published: (2009-08-01)

Molecular Factors Related to Gefitinib Efficacy in Advanced Non-small Cell Lung Cancer
by: Tao ZHOU, et al.
Published: (2010-03-01)

Research Progress on the Relationship between Insulin-like Growth Factor-I and Lung Cancer
by: Zhe LIU, et al.
Published: (2010-06-01)

Prognostic Significance of Cigarette Smoking in Association with Histologic Subtypes of Resected Lung Adenocarcinoma
by: Jung Hoon Yi, et al.
Published: (2019-10-01)

A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients with Non–Small-Cell Lung Cancer
by: Ramaswamy GOVINDAN
Published: (2010-04-01)

Circulating Lymphocyte Subsets  in Patients with Lung Cancer and Their Prognostic Value
by: Jun LUO, et al.
Published: (2011-08-01)

Prognostic outcome of treatment modalities for epidermal growth factor receptor-mutated advanced lung cancer
by: Seung Hun Jang, et al.
Published: (2022-07-01)

Clinicopathologic Features and Prognostic Implications in 72 Cases  with Lung Adenosquamous Carcinoma
by: Xi WU, et al.
Published: (2016-10-01)

Biostatistics /
by: Alcala, Katelynn, author 648622
Published: (2012)

Biostatistics series module 1: Basics of biostatistics
by: Avijit Hazra, et al.
Published: (2016-01-01)

CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer
by: Yi-Ying Wu, et al.
Published: (2017-02-01)

Prognostic significance of octamer-4 expression in primary lung adenocarcinoma
by: Taek Yong Ko
Published: (2021-01-01)

PET/CT as a Prognostic Factor for Small Cell Lung Cancer
by: Maher Soliman
Published: (2023-07-01)

Analysis of Prognostic Factors in NSCLC Patients with Brain Metastases  Diagnosed by Constrast-enhanced MRI After Whole Brain Radiotherapy
by: Hui LIU, et al.
Published: (2011-09-01)

Lung cancer : new research /
by: Carafaro, Robert L.
Published: (2005)

Clinicopathological and Prognostic Significance of a Panel of Tumor Biomarkers  in Lung Adenocarcinoma: a Tissue Microarray Study
by: Xin YANG, et al.
Published: (2014-03-01)

Chemotherapy Definitions and Policies for Thymic Malignancies
by: Nicolas Girard, et al.
Published: (2014-02-01)

Standard Terms, Definitions, and Policies for Minimally Invasive Resection of Thymoma
by: Alper Toker, et al.
Published: (2014-02-01)

Policies and Reporting Guidelines for Small Biopsy Specimens of Mediastinal Masses
by: Alberto Marchevsky, et al.
Published: (2014-02-01)

Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies
by: Daniel Gomez, et al.
Published: (2014-02-01)

Standard Outcome Measures for Thymic Malignancies
by: James Huang, et al.
Published: (2014-02-01)

Thymic Tumors Preface
by: Keneng CHEN, et al.
Published: (2014-02-01)

Expert Consensus on the Diagnosis and Treatment of Bone Metastasis  in Lung Cancer (2014 version)
by: Yan SUN, et al.
Published: (2014-02-01)

Which Way is Up? Policies and Procedures for Surgeons and Pathologists Regarding Resection Specimens of Thymic Malignancy
by: Frank C. Detterbeck, et al.
Published: (2014-02-01)

The Masaoka-Koga Stage Classification for Thymic Malignancies  Clarification and Definition of Terms
by: Frank C. Detterbeck, et al.
Published: (2014-02-01)

Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression
by: Editorial Office of Chinese Journal of Lung Cancer
Published: (2023-04-01)

A Case Report of Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement
by: Yehong MIAO, et al.
Published: (2017-05-01)